<p>The number of subjects recruited, enrolled, and lost at follow-up in a two-armed efficacy trial.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
<p>Number of subjects included and excluded for baseline and 4-year follow-up analyses.</p
<p>Likely effective, drugs to which isolate susceptible in laboratory testing. <i>n</i>, number of p...
<p>Number and proportion of initiated, completed, and published academic drug trials by year of appr...
<p>The number of patients by the number of events for each primary outcome, by the treatment group.<...
<p>The number of individuals screened, randomized, allocated and withdrawn from the trial.</p
<p>Number and Percentage of Terminated Trials by Proportion of Target Enrollment Met and whether res...
<p>Number of individuals included in the study, influenza vaccinations, and outcomes for each study ...
<p>Number of patients who had the follow up sample in each two-month period of time.</p
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Number of subjects and proportion of the population that died during the study time by age-span, ...
<p>Number of individuals screened, randomized and allocated to the three vaccination groups and with...
<p>Number of animals used per treatment group in the efficacy and safety experiments.</p
<p>Number of patients per arm for an active controlled trial with the number of new cortical lesions...
<p>Number of participants with follow-up measurements at each age for boys and girls.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
<p>Number of subjects included and excluded for baseline and 4-year follow-up analyses.</p
<p>Likely effective, drugs to which isolate susceptible in laboratory testing. <i>n</i>, number of p...
<p>Number and proportion of initiated, completed, and published academic drug trials by year of appr...
<p>The number of patients by the number of events for each primary outcome, by the treatment group.<...
<p>The number of individuals screened, randomized, allocated and withdrawn from the trial.</p
<p>Number and Percentage of Terminated Trials by Proportion of Target Enrollment Met and whether res...
<p>Number of individuals included in the study, influenza vaccinations, and outcomes for each study ...
<p>Number of patients who had the follow up sample in each two-month period of time.</p
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Number of subjects and proportion of the population that died during the study time by age-span, ...
<p>Number of individuals screened, randomized and allocated to the three vaccination groups and with...
<p>Number of animals used per treatment group in the efficacy and safety experiments.</p
<p>Number of patients per arm for an active controlled trial with the number of new cortical lesions...
<p>Number of participants with follow-up measurements at each age for boys and girls.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
<p>Number of subjects included and excluded for baseline and 4-year follow-up analyses.</p
<p>Likely effective, drugs to which isolate susceptible in laboratory testing. <i>n</i>, number of p...